LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 46.95 84.90 379 4952 0.0765 0.2905
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 46.95 84.90 2517 4952 0.5082 0.7821
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 48.65 84.90 178 5328 0.0334 0.1320
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 48.65 84.90 2605 5328 0.4889 0.7741
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 48.65 84.90 2762 5328 0.5183 0.7916
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 48.65 84.90 2780 5328 0.5217 0.7935
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 48.65 84.90 421 5328 0.0790 0.3075
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 48.65 84.90 2653 5328 0.4979 0.7796
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 50.36 84.90 242 5651 0.0428 0.1888
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 50.36 84.90 2751 5651 0.4868 0.7759
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 50.36 84.90 2898 5651 0.5128 0.7912
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 50.36 84.90 2912 5651 0.5153 0.7926
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 50.36 84.90 477 5651 0.0844 0.3298
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 50.36 84.90 2833 5651 0.5013 0.7845
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 52.06 84.90 279 5990 0.0466 0.2138
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 52.06 84.90 2865 5990 0.4782 0.7736
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 52.06 84.90 3029 5990 0.5056 0.7898
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 52.06 84.90 3041 5990 0.5076 0.7909
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 52.06 84.90 525 5990 0.0876 0.3454
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 52.06 84.90 2935 5990 0.4899 0.7806
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
 53.77 84.90 346 6252 0.0553 0.2542
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 53.77 84.90 3054 6252 0.4884 0.7818
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
 53.77 84.90 3147 6252 0.5033 0.7904
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 53.77 84.90 3163 6252 0.5059 0.7919
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
 53.77 84.90 587 6252 0.0939 0.3658
MN20160318_Q02
N12